Washington D.C., USA, 22-27 July 2012www.aids2012.org

WHERE ARE WE GOING?

IAS Members MeetingTuesday 24 July – Washington DC

Françoise Barré-SinoussiInstitut Pasteur - France

Washington D.C., USA, 22-27 July 2012www.aids2012.org

In 2 years of Elly’s Presidency, we have already come a long way

Thank You so much for your commitment

Washington D.C., USA, 22-27 July 2012www.aids2012.org

As a scientist…

Basic science and clinical research has generated & continue to generate important tools & knowledge about HIV to improve treatment, care and prevention.

I believe that applying scientific evidence and best practice at every level of the HIV response is the only way to tackle the HIV/AIDS epidemic.

It is unacceptable that the results of science are not implemented & made available for the benefit of all people

Washington D.C., USA, 22-27 July 2012www.aids2012.org

As a President of IAS and a Nobel laureate

I have a voice & the responsability for continouly advocating for the right to an evidence-based response to HIV (women & children, key affected populations…)

It is also my vision that we must reinforce dialog & cooperation with health professionals & decision makers fighting other diseases (including in research)

We must advocate for a better link between research & public health intervention

Remember that we are always stronger together!

Washington D.C., USA, 22-27 July 2012www.aids2012.org

6 priorities

TASP

Effectiveness & Efficiency

KAPs

Human Rights

HIV Cure

Social & Political Sciences

CONFERENCES

A powerful mean but not an end!

To connect, to promote, to mobilize, to advocate…

Washington D.C., USA, 22-27 July 2012www.aids2012.org

As a Woman….women represent 49% of all adults living with HIV. HIV remains the leading cause of death for women of reproductive age worldwide.

Too little research that has been pursued to address specific questions related to HIV infection in women or to systematically investigate sex differences.

IAS has with 15 other partners launch in 2010 a consensus statement aiming at advancing an HIV research agenda for women and children. This document describes 20 priority research questions to address the knowledge gap in this area.

Washington D.C., USA, 22-27 July 2012www.aids2012.org

We will continue to Advocate for a gender based approach in HIV research

IAS has also introduced in 2011 a gender policy to abstract submission to conferences & the journal of IAS to encourage authors to provide research results disaggregated by sex and to provide gender analysis.

Washington D.C., USA, 22-27 July 2012www.aids2012.org

Launch of the Global Scientific Strategy

.

The International AIDS Society scientific working group on HIV Cure. Towards an HIV cure: a global scientific strategy. Nature Rev. Immunol. 18 Jul 2012 (doi: 10.1038/nri.3262)

sign the Rome Statement for HIV Cure research to be accelerated:

www.iasociety.org

Washington D.C., USA, 22-27 July 2012www.aids2012.org

20 signatories: funders, activists, universities 3 press conferences in 3 languages Webcast and media kit Impact so far => 2500 hits

Media Launch, July 19th

Washington D.C., USA, 22-27 July 2012www.aids2012.org

Pre-conference Symposium, 20 and 21 July

A movement that has just begun!

Washington D.C., USA, 22-27 July 2012www.aids2012.org

HIV Cure : Next Steps

StakeholdersAdvisory

Board Þ Funding Coordination Focus

Þ Coordination of all components

Ethics Working Group

Cost-Effectiveness

Working Group

Information Exchange Database

Social Sciences Research Team

Industry Collaboration Group

Washington D.C., USA, 22-27 July 2012www.aids2012.org

WHERE ARE WE GOING?...

To Kuala Lumpur

Adeeba Kamarulzaman

“Towards an HIV Cure”Pre-conference symposium

28 & 29 June 2013Looking Forward to see you There

Washington D.C., USA, 22-27 July 2012www.aids2012.orgwww.aids2014.org

“Towards an HIV Cure”Pre-conference symposium?

Sharon Lewin

Washington D.C., USA, 22-27 July 2012www.aids2012.org

SIGN AT WWW.DCDECLARATION.ORG